Pneumocystis jirovecii dihydropteroate synthase gene mutations and human immunodeficiency virus-associated Pneumocystis pneumonia

Journal of Eukaryotic Microbiology

Volumn 53, Issue SUPPL. 1, 2006, Pages

  Huang, Laurence ^a,b,g   Welsh, David A ^c   Miller, Robert F ^d   Beard, C Ben ^e   Lawrence, Gena G ^f   Fox, Melissa ^f   Swartzman, Alexandra ^a   Bensley, Matthew R ^a   Carbonnet, Denise ^c   Davis, J Lucian ^b   Chi, Amy ^a   Yoo, Becky J ^a   Jones, Jeffrey L ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^f NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^g SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DIHYDROPTEROATE SYNTHASE; FUNGAL PROTEIN; SULFANILAMIDE DERIVATIVE;

FUNGUS; GENE; HUMAN IMMUNODEFICIENCY VIRUS; MUTATION; RESPIRATORY DISEASE;

AIDS RELATED COMPLEX; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; CHEMOPROPHYLAXIS; CLASSIFICATION; CONFERENCE PAPER; ENZYMOLOGY; EPIDEMIOLOGY; GENETICS; GEOGRAPHY; HOSPITAL; HUMAN; LUNG LAVAGE; MICROBIOLOGY; MUTATION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; RISK FACTOR; SPUTUM; UNITED STATES;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMINO ACID SUBSTITUTION; ANTI-INFECTIVE AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOPREVENTION; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE, FUNGAL; EPIDEMIOLOGY, MOLECULAR; FUNGAL PROTEINS; GEOGRAPHY; HOSPITALS; HUMANS; MUTATION; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; RISK FACTORS; SPUTUM; SULFANILAMIDES; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII;

EID: 33751370148     PISSN: 10665234     EISSN: 15507408     Source Type: Journal    
DOI: 10.1111/j.1550-7408.2006.00195.x     Document Type: Conference Paper

References (20)

1. Beard, C. B., Carter, J. L., Keely, S. P., Huang, L., Pieniazek, N. J., Moura, I. N., Roberts, J. M., Hightower, A. W., Bens, M. S., Freeman, A. R., Lee, S., Stringer, J. R., Duchin, J. S., del Rio, C., Rimland, D., Baughman, R. P., Levy, D. A., Dietz, V. J., Simon, P. & Navin, T. R. 2000. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg. Infect. Dis., 6:265-272.
2. Beard, C. B., Roux, P., Nevez, G., Hauser, P. M., Kovacs, J. A., Unnasch, T. R. & Lundgren, B. 2004. Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. Emerg. Infect. Dis., 10:1729-1735.
3. Benson, C. A., Kaplan, J. E., Masur, H., Pau, A. & Holmes, K. K. 2004. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm. Rep., 53:1-112.
4. Costa, M. C., Helweg-Larsen, J., Lundgren, B., Antunes, F. & Matos, O. 2003. Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveci isolates from Portuguese patients with Pneumocystis pneumonia. Int. J. Antimicrob. Agents, 22:516-520.
5. Crothers, K., Beard, C. B., Turner, J., Groner, G., Fox, M., Morris, A., Eiser, S. & Huang, L. 2005. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS, 19:801-805.
6. Helweg-Larsen, J., Benfield, T. L., Eugen-Olsen, J., Lundgren, J. D. & Lundgren, B. 1999. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet, 354:1347-1351.
7. Huang, L., Hecht, F. M., Stansell, J. D., Montanti, R., Hadley, W. K. & Hopewell, P. C. 1995. Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful? Am. J. Respir. Crit. Care Med., 151:1866-1871.
8. Huang, L., Beard, C. B., Creasman, J., Levy, D., Duchin, J. S., Lee, S., Pieniazek, N., Carter, J. L., del Rio, C., Rimland, D. & Navin, T. R. 2000. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J. Infect. Dis., 182:1192-1198.
9. Huang, L., Crothers, K., Atzori, C., Benfield, T., Miller, R., Rabodonirina, M. & Helweg-Larsen, J. 2004. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. Emerg. Infect. Dis., 10:1721-1728.
10. Iliades, P., Meshnick, S. R. & Macreadie, I. G. 2004a. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model. Antimicrob. Agents Chemother., 48:2617-2623.
11. Iliades, P., Meshnick, S. R. & Macreadie, I. G. 2005b. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs. Antimicrob. Agents Chemother., 49:741-748.
12. Kazanjian, P., Locke, A. B., Hossler, P. A., Lane, B. R., Bartlett, M. S., Smith, J. W., Cannon, M. & Meshnick, S. R. 1998. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS, 12:873-878.
13. Kazanjian, P., Armstrong, W., Hossler, P. A., Burman, W., Richardson, J., Lee, C. H., Crane, L., Katz, J. & Meshnick, S. R. 2000. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J. Infect. Dis., 182:551-557.
14. Lane, B. R., Ast, J. C., Hossler, P. A., Mindell, D. P., Bartlett, M. S., Smith, J. W. & Meshnick, S. R. 1997. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J. Infect. Dis., 175:482-485.
15. Ma, L., Borio, L., Masur, H. & Kovacs, J. A. 1999. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J. Infect. Dis., 180:1969-1978.
16. Ma, L., Kovacs, J. A., Cargnel, A., Valerio, A., Fantoni, G. & Atzori, C. 2002. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J. Infect. Dis., 185:1530-1532.
17. Meneau, I., Sanglard, D., Bille, J. & Hauser, P. M. 2004. Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae. Antimicrob. Agents Chemother., 48:2610-2616.
18. Morris, A., Lundgren, J. D., Masur, H., Walzer, P. D., Hanson, D. L., Frederick, T., Huang, L., Beard, C. B. & Kaplan, J. E. 2004. Current epidemiology of Pneumocystis pneumonia. Emerg. Infect. Dis., 10:1713-1720.
19. Navin, T. R., Beard, C. B., Huang, L., del Rio, C., Lee, S., Pieniazek, N. J., Carter, J. L., Le, T., Hightower, A. & Rimland, D. 2001. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study. Lancet, 358:545-549.
20. Stein, C. R., Poole, C., Kazanjian, P. & Meshnick, S. R. 2004. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia. Emerg. Infect. Dis., 10:1760-1765.